DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons
Business Model:
Revenue: $16.8M
Employees: 11-50
Address: 14612 Big Basin Way
City: Saratoga
State: CA
Zip: 95070
Country: US
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Contact Phone:
+16503291999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2007 | TearScience | Series B | 15.1M |
1/2023 | Milo | Series A | 0 |
1/2008 | Benvenue Medical | Series B | 15M |
5/2005 | Talima Therapeutics | Series A | 1.6M |
11/2009 | EndoGastric Solutions | Series E | 0 |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
3/2013 | Avedro | Series D | 0 |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
5/2008 | Astute Medical | Series A | 6.3M |
7/2006 | InSound Medical | Series E | 18.9M |
11/2009 | Spinal Modulation | Series C | 27.4M |
6/2012 | Benvenue Medical | Series D | 25M |
2/2008 | InSound Medical | Series E | 11M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
6/2014 | Benvenue Medical | Series E | 40M |
4/2003 | iScience Interventional | Series C | 15M |
7/2007 | CardioMind | Series C | 11M |
3/2008 | CardioMind | Venture Round | 22M |
12/2009 | EBR Systems | Venture Round | 15M |
3/2004 | Spinal Kinetics | Series A | 10M |
2/2009 | SynergEyes | Series C | 0 |
10/2005 | EBR Systems | Series B | 21M |
11/2007 | Viracta Therapeutics | Series A | 20M |
10/2008 | InSound Medical | Series E | 13M |
3/2006 | Cartilix | Series B | 6.3M |
4/2010 | Viracta Therapeutics | Series B | 12M |
10/2007 | Vitreoretinal Technologies | Series A | 12M |
3/2004 | InSound Medical | Series D | 17.2M |
11/2005 | FlowMedica | Series D | 0 |
4/2010 | Articulinx Inc. | Series B | 10M |
3/2011 | Astute Medical | Series B | 13M |
3/2012 | Viracta Therapeutics | Series B | 0 |
7/2008 | Sierra Surgical | Series B | 14.5M |
8/2007 | Sierra Surgical | Series A | 7.1M |
11/2005 | Ovalis | Series A | 0 |
5/2007 | Pulmonx | Series B | 20M |
3/2003 | iScience Surgical | Series B | 0 |
2/2011 | EBR Systems | Series D | 5M |
6/2004 | EBR Systems | Series A | 5.2M |
5/2010 | Astute Medical | Series B | 26.5M |
10/2005 | PhotoThera | Series B | 19M |
8/2001 | MicroVention Terumo | Series C | 12.5M |
9/2011 | Simpirica Spine | Series C | 22M |
7/2008 | MyoScience | Series B | 0 |
9/2013 | MyoScience | Series E | 0 |
3/2012 | MyoScience | Series D | 0 |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
8/2007 | EndoGastric Solutions | Series D | 30M |
1/2016 | Benvenue Medical | Equity | 23M |
6/2011 | Spinal Modulation | Series D | 0 |
5/2009 | PhotoThera | Series D | 50M |
7/2003 | Bacchus Vascular | Series D | 25M |
5/2007 | Talima Therapeutics | Series B | 19M |
5/2014 | EndoGastric Solutions | Series G | 0 |
4/2006 | PhotoThera | Series C | 30.5M |
4/2006 | SynergEyes | Series B | 0 |
4/2017 | Avedro | Venture Round | 0 |
6/2008 | EBR Systems | Series C | 35M |
5/2007 | TRIA Beauty | Series D | 0 |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
5/2009 | iScience Interventional | Series F | 20.5M |
1/2006 | Spinal Kinetics | Series B | 36M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
1/2002 | Renovis | Series B | 0 |
3/2005 | iScience Surgical | Series C | 0 |
12/2005 | Facet Solutions | Series B | 16.5M |
1/2008 | Avedro | Series A | 8M |
2/2011 | Spiracur | Series C | 35M |
2/2011 | TRIA Beauty | Venture Round | 26.3M |
4/2012 | WaveTec Vision | Venture Round | 0 |
1/2003 | Lumend | Series D | 23.2M |
1/2012 | iScience Interventional | Venture Round | 2.8M |
5/2010 | TearScience | Series C | 44.5M |
9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
4/2016 | TearScience | Series D | 0 |
1/2008 | POINT Biomedical | Private Equity Round | 0 |
10/2012 | TRIA Beauty | Venture Round | 7.5M |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
2/2009 | WaveTec Vision | Series C | 20.1M |
5/2011 | WaveTec Vision | Series D | 15.9M |
5/2007 | WaveTec Vision | Series B | 13M |
4/2011 | Benvenue Medical | Series C | 35.5M |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
6/2012 | Astute Medical | Series C | 40.4M |
1/2006 | Spinal Modulation | Series A | 7M |
3/2010 | Pulmonx | Series C | 0 |
6/2014 | Spinal Kinetics | Venture Round | 34M |
6/2009 | Spiracur | Series B | 20.3M |
1/2012 | Pulmonx | Private Equity Round | 0 |
5/2018 | Avedro | Series F | 0 |
1/2007 | Ovalis | Series B | 0 |
5/2018 | Avedro | Series F | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2016 | TearScience | Series D | 0 |
1/2016 | Benvenue Medical | Series F | 0 |
6/2014 | Benvenue Medical | Series E | 0 |
6/2014 | Spinal Kinetics | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | MyoScience | Series E | 0 |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|